KLK9 and ovarian carcinoma: Although there are some previous reports on expression and potential clinical relevance of KLK9, 10, 11, and 15 in ovarian cancer, in most studies rather heterogeneous patient cohorts were analyzed, including different histological subtypes such as low and high grade serous, mucinous and endometroid tumors.